A pet drug efficacy test and a field trial for the evaluation of pet drugs conducted by Taizhou Bioally Technology Co Ltd recently got the green light.
A new infliximab or intravenously injected drug produced by Taizhou Mabtech Pharmaceutical Co recently got the green light to be sold on the Peruvian market.
The Taizhou Medial High-tech Zone, located in Taizhou city, Jiangsu province, is persisting in making innovation the core of developing new quality productive forces.
The Yangtze River Pharmaceutical Group has prioritized the path to ecological and green development, improving level of green manufacturing technology.